Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register for free online access

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Free Full Text Free
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chaurand, P.
Right arrow Articles by Caprioli, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaurand, P.
Right arrow Articles by Caprioli, R. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Articles

Imaging Mass Spectrometry: Principles and Potentials

Pierre Chaurand, Sarah A. Schwartz, Michelle L. Reyzer and Richard M. Caprioli

Mass Spectrometry Research Center and Department of Biochemistry, Vanderbilt University Medical Center, Nashville, Tennessee 37212, USA

Correspondence: Address correspondence to: Richard Caprioli, Mass Spectrometry Research Center, 9160 MRB III, Vanderbilt University, Nashville, Tennessee 37232-8575, USA; e-mail:r.caprioli{at}vanderbilt.edu

Direct tissue profiling and imaging mass spectrometry (MS) allow for detailed mapping of the complex protein pattern across a tissue sample. Utilization of these tools provides spatial information across a tissue section for target protein expression and can be used to correlate changes in expression levels with specific disease states or drug response. Protein patterns can be directly correlated to known histological regions within the tissue, allowing for the direct monitoring of proteins specific for morphological regions within a tissue sample. Profiling and imaging MS have been used to characterize multiple tissues, including human gliomas and lung cancers, as well as tumor response to specific therapeutics, suggesting the use of proteomic information in assessing disease progression as well as predicting patient response to specific treatments. This article discusses both the technology and methods involved in analyzing proteins directly from tissue samples as well as several MS applications, including profiling human tumors, characterizing protein differences between tumor grades, and monitoring protein changes due to drug therapy.

Key Words: Mass spectrometry • tissue • protein • profiling • imaging • cancer

Abbreviations: MALDI MS, matrix-assisted laser desorption ionization mass spectrometry • ESI MS, electrospray ionization mass spectrometry • IMS, imaging mass spectrometry • m/z, mass-to-charge • OCT, Optimum Cutting Temperature • RP-HPLC, reverse phase high pressure liquid chromatography • CAD, collision activated dissociation

Toxicologic Pathology, Vol. 33, No. 1, 92-101 (2005)
DOI: 10.1080/01926230590881862


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
S. Ocak, P. Chaurand, and P. P. Massion
Mass Spectrometry-based Proteomic Profiling of Lung Cancer
Proceedings of the ATS, April 15, 2009; 6(2): 159 - 170.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
E. Szajli, T. Feher, and K. F. Medzihradszky
Investigating the Quantitative Nature of MALDI-TOF MS
Mol. Cell. Proteomics, December 1, 2008; 7(12): 2410 - 2418.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
D. A. N. Mustafa, P. C. Burgers, L. J. Dekker, H. Charif, M. K. Titulaer, P. A. E. S. Smitt, T. M. Luider, and J. M. Kros
Identification of Glioma Neovascularization-related Proteins by Using MALDI-FTMS and Nano-LC Fractionation to Microdissected Tumor Vessels
Mol. Cell. Proteomics, July 1, 2007; 6(7): 1147 - 1157.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Bouamrani, J. Ternier, D. Ratel, A.-L. Benabid, J.-P. Issartel, E. Brambilla, and F. Berger
Direct-Tissue SELDI-TOF Mass Spectrometry Analysis: A New Application for Clinical Proteomics
Clin. Chem., November 1, 2006; 52(11): 2103 - 2106.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Han and K. L. Schey
MALDI Tissue Imaging of Ocular Lens {alpha}-Crystallin.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2990 - 2996.
[Abstract] [Full Text] [PDF]